Company patents
NEURAVI LIMITED
NEURAVI LIMITED's patent strategy is heavily concentrated in Medical Diagnostics & Surgery, representing 89.4% of its portfolio, yet this core area saw a significant 60.0% decline in patenting activity in 2025. Surprisingly, despite a sharp drop in 2025, Drug Delivery Devices appears to be an emerging focus with a 36.4% year-over-year growth in patent filings so far in 2026, while Implants & Prosthetics and Healthcare Informatics have seen their patenting efforts completely cease since 2025.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
161 US filings (since 2023) · 4 categories · 6 themes
Minimally invasive medical devices, typically flexible tubes, inserted into body lumens to deliver substances, remove obstructions, or perform localized treatments like ablation, dialysis, or drainage.
Design and application of devices that are inserted into the body or implanted to treat diseases, modulate physiological functions, or repair anatomical structures.
Focuses on the mechanical design, articulation, and actuation of hand-held or robotic surgical instruments, including improvements in stapling, cutting, grasping, and tissue manipulation.
Implantable devices designed to repair, replace, or assist the function of blood vessels or heart structures, including stents, valves, and annuloplasty rings.
Systems and devices for delivering gases, aerosols, or pressure support to the respiratory system, often including interfaces like masks and sophisticated control mechanisms for therapeutic effect or airway management.
Systems and methods that use imaging technologies, computer vision, and augmented reality to provide real-time guidance, localization, and visualization during surgical procedures or for detailed anatomical assessment.
Patents
Showing 1-10 of 242